Recent advances in healthcare research have increasingly leveraged routinely collected administrative data to monitor cancer recurrence. This approach circumvents the delays and resource-intensive ...

Approximately 20% to 30% of men with prostate cancer experience disease recurrence within 5 years of therapeutic intervention. 1 A key challenge in managing these patients is a scarcity of accurate ...

Researchers have developed and validated a machine learning--based method to predict which patients with early-stage melanoma are most likely to experience a cancer recurrence. Most deaths from ...

Omitting race and ethnicity from colorectal cancer (CRC) recurrence risk prediction models could decrease their accuracy and fairness, particularly for minority groups, potentially leading to ...